Related Experiment Video
Updated: Jul 15, 2025
06:55
Ileectomy-induced Bile Overaccumulation in Mouse Intestine
Published on: August 21, 2017
9.5K
Small intestinal bacterial overgrowth: current update
Hammad Zafar1, Brenda Jimenez, Alison Schneider
1Department of Gastroenterology, Hepatology and Nutrition, Cleveland Clinic Florida, Weston, Florida, USA.
Current Opinion in Gastroenterology
|September 26, 2023
Summary
This review covers small intestinal bacterial overgrowth (SIBO), detailing its causes, symptoms, and diagnostic methods. Emerging non-antibiotic treatments show promise for managing this condition.
Area of Science:
- Gastroenterology
- Microbiology
Background:
- Small intestinal bacterial overgrowth (SIBO) is characterized by excess bacteria in the small intestine, leading to diverse gastrointestinal symptoms like bloating, diarrhea, and malabsorption.
- Traditionally diagnosed via jejunal aspirate, SIBO presents with symptoms including bloating, abdominal distension, diarrhea, nutrient deficiencies, and weight loss.
Approach:
- This review synthesizes current knowledge on SIBO, covering its etiology, risk factors, clinical presentation, and diagnostic strategies.
- Discusses advancements in diagnostic tools such as breath, capsule, and urine-based testing, enhancing diagnostic accuracy.
- Explores therapeutic options, including traditional antibiotic treatments and novel non-antibiotic approaches like probiotics, dietary changes, and prokinetic agents.
Key Points:
- Recent diagnostic advancements, including breath, capsule, and urine tests, have improved the detection of SIBO.
- Non-antibiotic treatment strategies are emerging as effective alternatives or adjuncts to traditional therapies.
- SIBO diagnosis relies on identifying bacterial overgrowth or altered composition in the small intestine, impacting nutrient absorption and causing GI distress.
Conclusions:
- Updated diagnostic methods offer improved yield and accessibility for SIBO detection.
- Non-antibiotic therapies present a promising frontier in SIBO management, potentially reducing reliance on antibiotics.
- Comprehensive management of SIBO involves accurate diagnosis and tailored therapeutic strategies, including novel approaches.
More Related Videos
Related Concept Videos
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
348
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
348
01:29Bacterial Flora of the Large Intestine
500
The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
500
01:17Drugs for Treatment of Diarrhea-Predominant IBS
200
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
200
01:17Irritable Bowel Syndrome I: Introduction
304
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
304
01:30Irritable Bowel Syndrome III: Medical and Nursing Management
225
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
225
01:21Inflammatory Bowel Disease V: Surgical Management
164
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
164